Sign inJoin waitlistJoin the waitlist

Aaron Rapoport

Associate Chief of the Hematology/Oncology Division · Univ of Maryland Sch of Med

Credentials: · · · ·

History

Hematology/Oncology Division · Univ of Maryland Sch of Med
Present
UM Marlene and Stewart Greenebaum Comprehensive Cancer Center · Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med
Present

University of Rochester Medicine
1988–1989
Internal Medicine
1986–1989
Harvard Medical School
1982–1986

Research

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
New England Journal of Medicine · 2022 · 1,350 citations
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Blood · 2013 · 987 citations
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Nature Medicine · 2015 · Co-first of 35 authors · 722 citations

Saurabh Dahiya
40 papers
Jean Yared
37 papers
Nancy Hardy
36 papers
Ashraf Badros
34 papers
Mehmet Kocoglu
30 papers
Djordje Atanackovic
29 papers
FL
Forat Lutfi
17 papers · 8 as a fellow
AB
Ali Bukhari
14 papers · 10 as a fellow
Barry Meisenberg
14 papers
FL
Frederick Locke
14 papers
Joseph McGuirk
13 papers
Madhurima Koka
13 papers · 1 as a fellow

Grants

Adoptive Transfer of Gene-Modified Autologous T-Cells Post-ASCT for Myeloma
National Cancer Institute · R01
Contact PI · $959.9K · University of Maryland Baltimore
2012–2017
Immunotherapy After ASCT for MM Using hTERT Vaccination + Vaccine-Primed T Cells
National Cancer Institute · R21
Contact PI · $709.8K · University of Maryland Baltimore
2007–2010
Immune Responses to T-Cell Expansion + PCV Immunization
National Cancer Institute · R21
Contact PI · $548K · University of Maryland Baltimore
2004–2007
University of Maryland Greenebaum Cancer Centersupport Grant
National Cancer Institute · P30
Project lead · $150.6K · University of Maryland Baltimore

Clinical trials

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1, Phase 2
University of Maryland Greenebaum Cancer Center
2006
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
Study chair · Completed · Phase 2
University of Pennsylvania
2011–2018
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
Study chair · Completed · Phase 1, Phase 2
University of Maryland, Baltimore
2001–2008
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Study chair · Completed · Phase 2
University of Maryland, Baltimore
1999–2008